Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1219-1224

  Waki, Yoshihiro ^a   Nomura, Masaaki ^a   Kasugai, Shohei ^b   Ohya, Keiichi ^b   Miyamoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOSARCOMA; ESTRADIOL BLOOD LEVEL; ESTROGEN RELEASE; FEMALE; HYPERCALCIURIA; LUTEINIZING HORMONE RELEASE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RAT;

ANIMALS; BONE AND BONES; BONE MARROW; CARCINOSARCOMA; CELLS, CULTURED; FEMALE; GONADOTROPIN-RELEASING HORMONE; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM TRANSPLANTATION; ORGAN SIZE; OSTEOPOROSIS; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033559211     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hilgard, P., Schmitt, W., Minne, H., and Ziegler, R. Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. Horm. Metab. Res., 2: 253-254, 1970.
2. Minne, H., Raue, F., Bellwinkel, S., and Ziegler, R. The hypercalcemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol., 78: 613-624, 1975.
3. Guaiani, A., Sabatini, M., Coccioli, G., Cristina, S., Garattiti, S., and Bartosek, I. An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate). Cancer Res., 45: 2206-2209, 1985.
4. Waki, Y., Miyamoto, K., Kasugai, S., and Ohya, K. Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production. Jpn. J. Cancer Res., 86: 470-476, 1995.
5. Miyamoto, K., Waki, Y., Horita, T., Kasugai, T., and Ohya, K. Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4. Biochem. Pharmacol., 54: 613-617, 1997.
6. Maniatopoulos, C., Sodek, J., and Melcher, A. H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Calcif. Tissue Res., 254: 317-330, 1988.
7. Kasugai, S. Bone marrow stromal cell culture as a bone formative experimental system: technical points and applications to bone research. In: H. Ogura (ed.), Pharmacological Approach to the Study of the Formation and the Resorption Mechanism of Hard Tissues, pp. 175-186. Tokyo: Ishiyaku-EuroAmerica, 1994.
8. Ozawa, S., and Kasugai, S. Evaluation of implant materials (hydroxyapatite, glassceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials, 17: 23-29, 1996.
9. Takahashi, N., Yamada, H., Yoshiki, S., Roodman, G. D., Mundy, G. R., Jones, S. J., Boyde, A., and Suda, T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology, 122: 1373-1382, 1988.
10. Soekanto, A., Ohya, K., and Ogura, H. The effect of sodium salicylate on the osteoclast-like cell formation and bone resorption in a mouse bone marrow culture. Calcif. Tissue Int., 54: 290-295, 1994.
11. Azad, N., Emanuele, V. N., Halloran, M. M., Tentler, J., and Kelley, R. M. Presence of luteinizing hormone-releasing hormone (LHRH) mRNA in rat spleen lymphocytes. Endocrinology. 128: 1679-1681, 1991.
12. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., and Manolagas, S. C. 17-β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest., 89: 883-891, 1992.
13. Yasuda, H., Shima, N., Yano, K., Goto, M., Murakami, A., Tsuda, E., Mochizuki, S., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95: 3597-3602, 1998.
14. Rosenberg, E. M., Hahn, T. J., Orth, D. N., Deftos, L. J., and Tanaka, K. ACTH-secreting medullary carcinoma of the thyroid presenting a severe idiopathic osteoporosis and senile purpura: report of a case and review of the literature. J. Clin. Endocrinol. Metab., 47: 255-262, 1978.
15. Stiegler, C., Leb, G., Kleinert, R., Warnkross, H., Ramschak-Schawarzer, S., Lipp, R., Clarici, G., Krejs, G. J., and Dobnig, H. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J. Bone Miner. Res., 10: 751-759, 1995.
16. Adler, R. A., Evani, R., Mansouri, A., and Krieg, R. J., Jr. Relative effects of prolactin excess and estrogen deficiency on bone in rats. Metabolism, 47: 425-428, 1998.
17. Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., Hudson, P. J., Martin, T. J., and Wood, W. I. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (Washington DC), 237: 893-896, 1987.
18. Scharla, S. H., Minne, H. W., Lempert, U. G., Krieg, P., Rappel, S., Maurer, E., Grohe, U., and Ziegler, R. Osteolylic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP). Horm. Metab. Res., 23: 66-69, 1991.
19. De Miguel, F., and Esbrit, P. Isolation of a 18000-Da molecular weight form of parathyroid hormone-related protein from the rat Walker carcinosarcoma 256. Cancer Lett., 66: 201-206, 1992.
20. Devogelaer, J. P. Nagant de Deuxchaisnes, C. Donnez, J., and Thomas, K. LHRH analogues and bone loss. Lancet, 1: 1498, 1987.
21. Saggese, G., Bertelloni, S., Baroncelli, G. I., Pardi, D., and Cinquanta, L. Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion. J. Endocrinol. Invest., 14: 231-236, 1991.
22. Goulding, A., and Fisher, L. 17β-Estradiol protects rats from osteopenia associated with administration of the luteinizing hormone-releasing hormone (LHRH) agonist. buserelin. Bone Miner. 13: 47-53, 1991.
23. Ernst, M., Schmid, C., and Froesch, E. R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc. Natl. Acad. Sci. USA, 85: 2307-2310, 1988.
24. Ernst, M., and Rodan, G. A. Estradiol regulation of insulin-like growth factor-1 expression in osteoblastic cells: evidence for transcriptional control. Mol. Endocrinol., 5: 1081-1089, 1991.
25. Gehron, R. P., Young, M. F., Flanders, K. C. Roche, N. S., Kondaiah, P. Reddi, A. H., Termine, J. D., Sporn, M. B., and Roberts, A. B. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J. Clin. Biol., 105: 457-463, 1987.
26. Komm, B. S., Terpening, C. M., Benz, D. J., Graeme, K. A., Gallegos, A., Kore, M., Greene, G. L., O'Malley, B. W., and Haussler, M. R. Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science (Washington DC), 241: 81-84, 1988.
27. Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurty, C., Avioli, L. V., and Peck, W. A. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc. Natl. Acad. Sci. USA, 86: 2398-2402, 1989.
28. Ralston, S. H., Russell, R. G. G., and Gowen, M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res., 5: 983-989, 1990.
29. Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., and Avioli, L. V. The effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA, 88: 5134-5138, 1991.
30. Jilka, R. L., Hangoc, G., Girsole, G., Passen, G., Williams, D. C., Abrams, J. S., Boyee, B., Broxmeyer, H., and Manolagas, S. C. Increased osteoclast development after estrogen loss, mediation by interleukin-6. Science (Washington DC), 257: 88-91, 1992.
31. Wronski, T. J., Walsh, C. C., and Iganaszewski, L. A. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone, 7: 119-123, 1986.
32. Tobias, J. H., Chambers, T. J., and Gallagher, A. Effect of administration and subsequent cessation of buserelin on cancellous bone of female rats. J. Bone Miner. Res., 9: 1919-1925, 1994.